HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy

HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy

In this episode, Keith S. Kaye, MD, MPH; Lilian Abbo, MD, FIDSA; and Jason M. Pogue, PharmD, discuss HABP/VABP and gram-negative resistance including:

  • Epidemiology and burden of nosocomial bacterial pneumonia
  • Patient-specific risk factors for MDR pathogens
  • Improving outcomes with the use of antibiograms
  • Recommended empiric therapy for clinically suspected VABP
  • Antimicrobial resistance in HABP/VABP
  • Algorithms for gram-negative organism antibiotic-susceptibility testing
  • Using rapid diagnostic tests for HABP/VABP
  • New antimicrobial agents for MDR gram-negative infections with discussion of the 2021 IDSA guidance, and the following studies:
    • ASPECT-NP: ceftolozane/tazobactam vs meropenem
    • REPROVE: ceftazidime/avibactam vs meropenem
    • RESTORE-IMI-1 imipenem/cilastatin/relebactam vs colistin + imipenem
    • RESTORE-IMI-2: imipenem/cilastatin/relebactam vs piperacillin/tazobactam
    • APEKS-NP: cefiderocol vs meropenem
    • CREDIBLE-CR: cefiderocol vs best available therapy

Program Director:

Keith S. Kaye, MD, MPH
Chief
Division of Allergy, Immunology and Infectious Diseases
Professor of Medicine
Rutgers Robert Wood Johnson
Medical School
New Brunswick, New Jersey

Faculty:

Lilian Abbo, MD, FIDSA
Associate Chief Medical Officer in Infectious Diseases
Jackson Health System
Professor of Infectious Diseases
Department of Medicine & Miami Transplant Institute
University of Miami Miller School of Medicine
Miami, Florida

Jason M. Pogue, PharmD
Clinical Professor
Department of Clinical Pharmacy
University of Michigan College of Pharmacy
Infectious Diseases Clinical Pharmacist
Michigan Medicine
Ann Arbor, Michigan

Content based on a CME program supported by an educational grant from Merck Sharp & Dohme Corp.

Follow along with a downloadable slideset at:
https://bit.ly/3CEop6h

Link to full program
https://bit.ly/3i781lf


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(506)

Beyond the “Pneumonia Shot”: Explaining the Full Benefits of Pneumococcal Vaccines to Patients

Beyond the “Pneumonia Shot”: Explaining the Full Benefits of Pneumococcal Vaccines to Patients

Just as pneumonia isn’t “just a cold,” the pneumococcal vaccine does much more than just protect yourself or your child against pneumonia. Listen in and learn from experts Robert H. Hopkins, Jr., MD, ...

1 Heinä 21min

Heading Off Misinformation and Disinformation: Pressure Points in Pediatric Vaccines Podcast 3

Heading Off Misinformation and Disinformation: Pressure Points in Pediatric Vaccines Podcast 3

In the final episode of a 3-part series, featuring audio from a live symposium, experts Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP, Patricia Stinchfield, MS, RN, PNP, and Jennifer M. Walsh, DNP, CPN...

18 Kesä 23min

Countering Myths and Mixed Messages: Pressure Points in Pediatric Vaccines Podcast 2

Countering Myths and Mixed Messages: Pressure Points in Pediatric Vaccines Podcast 2

In the second episode of a 3-part series featuring audio from a live symposium, experts Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP, Patricia Stinchfield, MS, RN, PNP, and Jennifer M. Walsh, DNP, CPN...

18 Kesä 21min

Don’t You Wish You Pneumo? Why We Continue to Update Our Pneumococcal Vaccine Strategy

Don’t You Wish You Pneumo? Why We Continue to Update Our Pneumococcal Vaccine Strategy

Pneumococcal vaccine recommendations are constantly evolving to respond to shifting patterns of infections, which is a good thing. However, the nuances can be complicated to explain to patients. Liste...

5 Kesä 17min

DeLIVERing Prevention Podcast: Optimizing Uptake of Hepatitis A and B Vaccination

DeLIVERing Prevention Podcast: Optimizing Uptake of Hepatitis A and B Vaccination

Viral hepatitis is an ongoing public health threat, despite the long-standing availability of effective vaccines for hepatitis A and B. Here, experts Paul Kwo, MD, Jewel Mullen, MD, MPH, MPA, FACP, an...

1 Kesä 37min

Evolving ART Switch Options Podcast

Evolving ART Switch Options Podcast

Listen in to learn the latest on ART switch strategies for people living with virologically suppressed HIV. Hear from experts Chloe Orkin, MBChB, FRCP, MD, and Peter J. Ruane, MD, as they review how t...

15 Touko 28min

Advances in ART Podcast: Putting New Data on Emerging Options in Context

Advances in ART Podcast: Putting New Data on Emerging Options in Context

Listen now as experts, Chloe Orkin, MBChB, FRCP, MD, and Jihad Slim, MD, explore the potential clinical implications of new data on novel options for optimizing HIV therapy, especially for treatment-e...

8 Touko 23min

My Take on Hepatitis B Challenges in the African Immigrant Community

My Take on Hepatitis B Challenges in the African Immigrant Community

Listen as Bright Ansah, patient advocate, describes his experience with being diagnosed with chronic hepatitis B as a recent immigrant to the United States and the unique barriers to treatment faced b...

7 Touko 7min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-liian-kuuma-peruna
rss-arkea-ja-aurinkoa-podcast-espanjasta
kesken
rss-luonnollinen-synnytys-podcast
aamukahvilla
rss-perho-rajoilla
rss-koira-haudattuna
mielipaivakirja
rss-narsisti
rss-rahataito-podcast
solu-ja-molekyylibiologian-perusteet
ensihoidon-ja-pelastustyoncast
rss-niinku-asia-on
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-hereilla
taytta-tavaraa
rss-duodecim-lehti